Diabetes is associated with poor short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure

Han Hu,Xinxin Hu,Caiyun Tian,Yanping Zhu,Yujuan Liu,Qijiao Cheng,Fangwan Yang,Jun Liu,Ying Li,Shide Lin
DOI: https://doi.org/10.1007/s12072-021-10243-1
IF: 9.029
2021-08-10
Hepatology International
Abstract:Background/purposeAssociations between the disturbances in glucose homeostasis and prognosis in patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) remain unclear. This study was conducted to investigate the clinical characteristics of disturbances in glucose homeostasis and their associations with 90-day mortality in patients with HBV-related ACLF.MethodsNinety-six patients with HBV-related ACLF without pre-existing diabetes were prospectively included. Glucose abnormalities were diagnosed based on fasting plasma glucose and oral glucose tolerance test results on admission and during follow-up. Homeostasis model assessment was used to establish insulin resistance (HOMA2-IR), insulin sensitivity (HOMA2-IS) and HOMA2-β-cell function (HOMA2-β). Multivariate Cox proportional hazards analysis was used to identify independent risk factors for death within 90 days after admission.ResultsAmong 96 patients with ACLF, 51 (53.1%) had diabetes, 29 (30.2%) had impaired glucose tolerance (IGT), and 17 (17.7%) had hypoglycemia. Patients with diabetes had significantly lower levels of HOMA2-β than did patients with normal glucose tolerance. Of 22 patients with diabetes or IGT and without anti-hyperglycemic treatment, 8 (36.4%) exhibited regression of their glucose metabolism disorders after a follow-up of 32.8 ± 28.8 days, and higher platelet levels were associated with regression. Twenty-five patients (25.0%) with ACLF died of liver failure within 90 days. Diabetes [odds ratio (OR) 3.601, 95% confidence interval (CI) 1.342–9.661] and age (OR 1.045, 95% CI 1.010–1.082) were the independent risk factors associated with mortality.ConclusionImpaired pancreatic β-cell function is related to diabetes development, and diabetes is associated with high mortality in patients with chronic HBV-related ACLF.
gastroenterology & hepatology
What problem does this paper attempt to address?
### What problems does this paper attempt to solve? This paper aims to explore the clinical features of glucose homeostasis disorders and their relationship with 90 - day mortality in patients with hepatitis B virus (HBV) - related acute - on - chronic liver failure (ACLF). Specifically, the main objectives of the study include: 1. **Evaluate the clinical features of glucose homeostasis disorders**: - The study included 96 HBV - related ACLF patients without a history of diabetes. - Abnormal blood glucose was diagnosed by fasting plasma glucose (FPG) and oral glucose tolerance test (OGTT). - Insulin resistance (HOMA2 - IR), insulin sensitivity (HOMA2 - IS) and β - cell function (HOMA2 - β) were calculated using the homeostasis model assessment 2 (HOMA2). 2. **Analyze the relationship between glucose homeostasis disorders and 90 - day mortality**: - A multivariate Cox proportional hazards model was used to identify independent risk factors. - The results showed that diabetes and age were independent risk factors for death within 90 days. 3. **Explore the dynamic changes of glucose metabolism disorders**: - The OGTT was repeated in 22 patients who did not receive hypoglycemic treatment to observe the regression of their glucose metabolism disorders. - It was found that platelet level (PLT) and albumin level (ALB) were related to the regression of glucose metabolism disorders. ### Main findings - **Diabetes is an independent risk factor for 90 - day mortality**: The 90 - day mortality risk in diabetic patients was significantly increased (OR 3.601, 95% CI 1.342–9.661). - **Hypoglycemia is not a risk factor for 90 - day mortality**: Although hypoglycemia is common in ACLF patients, this study did not find a significant association between it and 90 - day mortality. - **Impaired islet β - cell function is associated with the development of diabetes**: The HOMA2 - β level in diabetic patients was significantly lower than that in patients with normal glucose tolerance. ### Conclusion This study shows that diabetes is closely related to the high mortality rate in HBV - related ACLF patients, and impaired islet β - cell function is a key factor in the development of diabetes. Understanding the characteristics of these glucose metabolism disorders is helpful for improving the clinical management and prognosis of such patients.